Skip to main navigation Skip to search Skip to main content

Safety/Tolerability of Betaseron 500mg Subcutaneously Every Other Day and Betaseron 250mg Every Other Day For Patients With Relapsing Remitting Multiple Sclerosis

Project: Research

Project Details

StatusFinished
Effective start/end date12/20/02 → 06/27/09

Funding

  • Berlex Laboratories Inc: $128,338.00